Delivery Order SPE2DB22D1017-SPE2DB25FF2MN

Award Date 1/2/25
Potential Completion Date 1/3/25
Potential Value $1.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,617.98, is for the delivery of 4566905761 Vyvanse 60 mg capsules in 100s. The contract is a firm fixed-price delivery order, with a completion date of January 13, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,151.02, is for the provision of Vyvanse 70 mg capsules to support federal healthcare programs. The contract is a firm fixed-price delivery order, with an ultimate completion date of January 9, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) that...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Vyvanse 30 mg capsules. The $1,210.36 firm fixed-price contract has a completion date of November 18, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) worth $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $14,850.37, is for the provision of 4,564,977,305 units of the medication Vyvanse 60 mg capsules. The contract has a firm-fixed price pricing type and a completion date of June 18, 2024. This award is a child contract under a larger Indefinite Delivery Contract (IDC) held by...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,388.96 firm fixed-price delivery order is for the supply of Vyvanse 60 mg capsules in 100-count bottles. The contract has a completion date of November 8, 2024 and was awarded on November 7, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen...
This is a $17,416.88 delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 100 units of 40 mg Vyvanse capsules, with a performance period through May 2, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC covers a comprehensive...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,134.19 firm-fixed-price contract is for the supply of Vyvanse 40mg capsules. It is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999 through December 2025, which enables AmerisourceBergen to deliver a comprehensive range of medical commodities to support military treatment programs and...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The $6,120.52 firm fixed-price contract is for the supply of Vyvanse 50mg capsules, a prescription medication. The ultimate completion date is September 11, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,565,391 units of Vyvanse 20 mg capsules. The contract has a firm fixed price of $1,931.73 and a completion date of August 9, 2024. The award is not associated with any set-aside program. This delivery order is part of a broader Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,053.61, is for the delivery of Vyvanse 10 mg capsules. The contract is a firm fixed-price, delivery order contract with a completion date of January 4, 2024. This award is not associated with a set-aside program, indicating it was an open competition. AmerisourceBergen Drug Corp holds a...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB25FF2MN
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,757.90, is for the supply of Vyvanse 60 mg capsules to support federal healthcare programs. The contract is a firm fixed-price delivery order that runs through January 3, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and expiring in November 2026. The IDC covers a comprehensive range of pharmaceutical products and medical supplies for military healthcare programs globally. The contract has no set-aside designation, indicating open competition.

Generated 4/3/25, 10:01 AM